I think the appointment of Professor Prince is a game changer. He has a world renown reputation with a wide experience in many fields and is active. He has 450 research papers in his name and " has contributed to the successful development of several new cancer therapies now in use worldwide."..."In addition to advancing revolutionary new targeted therapies like PTX-100, Professor Prince has pioneered the research and development of Chimeric Antigen Receptor T-cell (CAR-T) therapies in Australia." He would not get involved at this level just for the money...his reputation is far more important. Additionally any potential licensing agreements down the track will his name attached to it will be very helpful. Also potential fund managers will sit up and take notice.
I am quietly confident this SP range 6.0c-7.5c will get broken in the short term.. any way my shares are in the safe awaiting some good announcements
PTX Price at posting:
6.7¢ Sentiment: Buy Disclosure: Held
